Research reference

Pinealon

A source-linked reference on Pinealon in oxidative-stress cell experiments. Sources checked 6 September 2026.

Source and review status

Published sources checked

Sources checked on: 6 September 2026

Qualified clinical review: Pending. This page has not been clinically reviewed.

About this source check

AI-assisted editorial source checking covers the cited material and its stated limits. It is not a systematic review, verification of a supplied product, or clinical sign-off.

Editorial role: InfoAddict. Last material change: 6 September 2026. Next source review: 6 December 2026.

Identity

The cited paper identifies Pinealon as the synthetic tripeptide Glu-Asp-Arg. That named research identity does not verify a particular product’s composition or manufacturing quality.

Sources: PubMed, National Library of Medicine

Research context

The work measured oxidative-stress and cell-cycle-related outcomes in cerebellar granule cells, neutrophils and PC12 cells. It is an in-vitro study, not a trial in people.

Sources: PubMed, National Library of Medicine

Evidence boundary

These laboratory observations cannot establish cognitive, ageing or neurological benefit in people. They also do not provide clinical safety, dosing or product-quality information.

Sources: PubMed, National Library of Medicine

This source-linked record does not establish a diagnosis, treatment effect, product quality, or personal suitability.

The named cell types and induced oxidative-stress conditions are specific to the experiment, which limits generalisation to normal physiology or human cognition.

Independent replication, clinical pharmacology and human outcome work would be needed before the experimental signal could inform a health claim.

Published sources

  1. Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes

    PubMed, National Library of Medicine. Published 2011; accessed 6 September 2026.

    Supports: The article identifies Pinealon as synthetic Glu-Asp-Arg and reports cell experiments.

Change history

DateChangeClinical-review status
6 September 2026Source-linked reference publishedPending

Keep a private record

UpgradeYourself lets you keep private records of routines and observations you choose to discuss with a qualified health professional. This reference does not recommend starting, stopping or changing an item.